[1] Beckers A, Petrossians P, Hanson J, et al.The causes and consequences of pituitary gigantism[J]. Nat Rev Endocrinol, 2018,14:705-720. [2] Katznelson L, Laws ER, Melmed S, et al. Acrome-galy: An endocrine society clinical practice guideline[J]. J Clin Endocrinol Metab, 2014,99:3933-3951. [3] Xia Z, Guo X, Zhou Q, et al. Somatotrophic adenoma in children younger than 14 years: Clinical features and treatment of 22 cases at a large pituitary center[J]. World Neurosurg, 2018,112:e561-e568. [4] Juul A, Bang P, Hertel NT, et al. Serum insulin-like growth factor-Ⅰ in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testi-cular size, and body mass index[J]. J Clin Endocrinol Metab, 1994,78:744-752. [5] Kane LA, Leinung MC, Scheithauer BW, et al. Pituitary adenomas in childhood and adolescence[J]. J Clin Endocrinol Metab, 1994,79:1135-1140. [6] Saggese G, Cesaretti G, Franchi G, et al. Testosterone-induced increase of insulin-like growth factor I levels depends upon normal levels of growth hormone[J]. Eur J Endocrinol, 1996,135:211-215. [7] Meinhardt UJ, Ho KK. Modulation of growth hormone action by sex steroids[J]. Clin Endocrinol (Oxf), 2006,65:413-422. [8] Parkinson C, Ryder WD, Trainer PJ. The relationship between serum GH and serum IGF-I in acromegaly is gender-specific[J]. J Clin Endocrinol Metab, 2001,86:5240-5244. [9] Guaraldi F, Storr HL, Ghizzoni L, et al. Paediatric pituitary adenomas: A decade of change[J]. Horm Res Paediatr, 2014,81:145-155. |